#VisualAbstract Reduced-dose lenalidomide regimen significantly prolongs event-free survival in elderly, intermediate-fit patients with newly diagnosed multiple myeloma
RelatedReports
Popular Reports
Peripherally inserted central catheters are associated with twice as many complications than midline catheters when used short-term
Capecitabine + oxaliplatin chemoradiotherapy does not increase survival, but increases toxicity, compared to capecitabine alone in the postoperative treatment of rectal cancer
The Child-Pugh score: Prognosis in chronic liver disease and cirrhosis [Classics Series]
Ultrasound features associated with shoulder complaints
Automated pupillometry may be helpful in opioid agonist therapy dosing for opioid use disorder
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.